245 related articles for article (PubMed ID: 26101938)
41. Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation.
Raevens S; De Pauw M; Reyntjens K; Geerts A; Verhelst X; Berrevoet F; Rogiers X; Troisi RI; Van Vlierberghe H; Colle I
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):495-502. PubMed ID: 23242127
[TBL] [Abstract][Full Text] [Related]
42. Extracorporeal membrane oxygenation rescue therapy in a case of portopulmonary hypertension during liver transplantation: a case report.
Stratta C; Lavezzo B; Ballaris MA; Panio A; Crucitti M; Andruetto P; Fanelli V; Grosso Marra W; Ranieri MV; Salizzoni M
Transplant Proc; 2013 Sep; 45(7):2774-5. PubMed ID: 24034045
[TBL] [Abstract][Full Text] [Related]
43. Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension.
Minder S; Fischler M; Muellhaupt B; Zalunardo MP; Jenni R; Clavien PA; Speich R
Eur Respir J; 2004 Oct; 24(4):703-7. PubMed ID: 15459152
[TBL] [Abstract][Full Text] [Related]
44. [Pulmonary hypertension complicating portal hypertension: portopulmonary hypertension].
Katsuta Y; Zhang XJ; Aramaki T
Nihon Rinsho; 2001 Jun; 59(6):1186-92. PubMed ID: 11411134
[TBL] [Abstract][Full Text] [Related]
45. Secure Combination Therapy With Low-Dose Bosentan and Ambrisentan to Treat Portopulmonary Hypertension Minimizing Each Adverse Effect.
Muraoka H; Imamura T; Hatano M; Maki H; Yao A; Kinugawa K; Komuro I
Int Heart J; 2015; 56(4):471-3. PubMed ID: 26084462
[TBL] [Abstract][Full Text] [Related]
46. Successful adult-to-adult living donor liver transplantation in a patient with moderate to severe portopulmonary hypertension.
Uchiyama H; Soejima Y; Taketomi A; Yoshizumi T; Harada N; Ijichi H; Yonemura Y; Maehara Y
Liver Transpl; 2006 Mar; 12(3):481-4. PubMed ID: 16498645
[TBL] [Abstract][Full Text] [Related]
47. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension.
Kuo PC; Johnson LB; Plotkin JS; Howell CD; Bartlett ST; Rubin LJ
Transplantation; 1997 Feb; 63(4):604-6. PubMed ID: 9047158
[TBL] [Abstract][Full Text] [Related]
48. Early initiation of prostacyclin in portopulmonary hypertension: 10 years of a transplant center's experience.
Awdish RL; Cajigas HR
Lung; 2013 Dec; 191(6):593-600. PubMed ID: 23979006
[TBL] [Abstract][Full Text] [Related]
49. Use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: a review of six patients.
Patel N
Neonatology; 2012; 102(2):130-6. PubMed ID: 22710735
[TBL] [Abstract][Full Text] [Related]
50. [Epoprostenol in the treatment of portopulmonary hypertension].
Culafić D; Culafić-Vojinović V; Jesić R
Srp Arh Celok Lek; 2003; 131(5-6):271-4. PubMed ID: 14692137
[TBL] [Abstract][Full Text] [Related]
51. Portopulmonary hypertension associated with congenital absence of the portal vein treated with bosentan.
Hino T; Hayashida A; Okahashi N; Wada N; Watanabe N; Obase K; Neishi Y; Kawamoto T; Okura H; Yoshida K
Intern Med; 2009; 48(8):597-600. PubMed ID: 19367055
[TBL] [Abstract][Full Text] [Related]
52. Management of Severe Portopulmonary Hypertension With Dual Oral Therapy Before Liver Transplantation.
Vionnet J; Yerly P; Aubert JD; Pascual M; Aldenkortt F; Berney T; Giostra E; Moradpour D; Schiffer E
Transplantation; 2018 May; 102(5):e194. PubMed ID: 29485510
[No Abstract] [Full Text] [Related]
53. Portopulmonary hypertension and hepatopulmonary syndrome.
Aldenkortt F; Aldenkortt M; Caviezel L; Waeber JL; Weber A; Schiffer E
World J Gastroenterol; 2014 Jul; 20(25):8072-81. PubMed ID: 25009379
[TBL] [Abstract][Full Text] [Related]
54. Portopulmonary hypertension.
Golbin JM; Krowka MJ
Clin Chest Med; 2007 Mar; 28(1):203-18, ix. PubMed ID: 17338936
[TBL] [Abstract][Full Text] [Related]
55. [Pulmonary complications of hepatic cirrhosis: portopulmonary hypertension and hepatopulmonary syndrome. The paradox of pulmonary vasoconstriction and vasodilation].
Chávez-Tapia NC; Uribe M; López E
Gac Med Mex; 2007; 143(4):333-9. PubMed ID: 17969842
[TBL] [Abstract][Full Text] [Related]
56. Combination therapy for severe portopulmonary hypertension in a child allows for liver transplantation.
Serrano RM; Subbarao GC; Mangus RS; Montgomery G; Johansen M
Pediatr Transplant; 2019 Aug; 23(5):e13461. PubMed ID: 31062925
[TBL] [Abstract][Full Text] [Related]
57. [Severe refractory pulmonary hypertension after liver transplantation for hepatitis C liver cirrhosis].
Dietrich CG; Gartung C; Siewert E; Lammert F; Matern S; Geier A
Z Gastroenterol; 2006 Jan; 44(1):33-7. PubMed ID: 16397837
[TBL] [Abstract][Full Text] [Related]
58. An evidence-based approach to the management of pulmonary arterial hypertension.
Archer SL; Michelakis ED
Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
[TBL] [Abstract][Full Text] [Related]
59. Successful liver transplantation in a child with severe portopulmonary hypertension treated with epoprostenol.
Laving A; Khanna A; Rubin L; Ing F; Dohil R; Lavine JE
J Pediatr Gastroenterol Nutr; 2005 Oct; 41(4):466-8. PubMed ID: 16205516
[No Abstract] [Full Text] [Related]
60. Portopulmonary hypertension: state of the art.
Porres-Aguilar M; Zuckerman MJ; Figueroa-Casas JB; Krowka MJ
Ann Hepatol; 2008; 7(4):321-30. PubMed ID: 19034231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
